Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

CGMs available on prescription from August 2022

Anyone with type 1 diabetes can now access real-time continuous glucose monitoring (CGM) through their GP or local hospital. Once prescribed, repeat prescriptions can be collected from local pharmacies.
Breakthrough T1D profile picture
Kate Lawton 2 August 2022

A young woman wearing a continuous glucose monitor

Anyone with type 1 diabetes can now access real-time continuous glucose monitoring (CGM) through their GP or local hospital. Once prescribed, repeat prescriptions can be collected from local pharmacies.

The Dexcom ONE Real Time-Continuous Glucose Monitoring can now be prescribed on the NHS, across all four nations of the UK. This will help put into action the recently updated NICE guidelines in England and Wales on blood glucose monitoring, which say that anyone with type 1 should be offered CGM or flash glucose monitoring as part of standard care.

Patients will be provided with a sensor, transmitter and information on how to use it. The Dexcom ONE has much of the same functions as the G6 device, except for sharing and looping capabilities. Read the differences between the Dexcom devices.

What are CGMs and how can they help people with type 1?

CGMs use a sensor attached to the body which transmits real-time information on glucose levels to a handset or the user’s mobile phone, allowing them to check their glucose levels more often and without the need for painful finger prick tests.

CGMs also alert the user when glucose levels become too low or too high, meaning they are better able to avoid dangerous hypoglycaemia (hypos) or hyperglycaemia (hypers) which can potentially cause long-term complications. They also allow the user to review their glucose trends over time, rather than just giving a snapshot of when the test is taken, as is the case with finger prick tests.

Our work with tech partners

We’ve been working with partners like Dexcom and organisations like NICE and NHS England to help bring about this sort of change for people with type 1.

Our Senior Technology Access Specialist, Lesley Jordan, says: “This is a major breakthrough in the treatment of type 1 diabetes which should allow everyone with type 1 access to this life changing technology. JDRF will work with local decision makers and people with type 1 diabetes to ensure equitable access to glucose monitoring technology as recommended by NICE.”

What do you need to do now?

Whilst this device is now available to be prescribed on the NHS, it may take some time to be rolled out in all areas across the UK. People with type 1 should ask their clinician at their next appointment if it is available in their area, and if not, when it will be.

Read more
Two young people sat in a park, with type 1 diabetes continuous glucose monitor visible on their arms
Breakthrough T1D
20 June 2025

Warning issued for Dexcom G6 users as Android 16 update causes compatibility issues

If you use the Dexcom G6 app on your Android smartphone, the newest Android 16 operating system may disrupt how the app functions.

Read more
Two older men at home reading type 1 diabetes information booklets.
Research
17 June 2025

Healthcare systems unprepared for rising number of older adults with T1D

We're calling for urgent reform as new report reveals older people with T1D are systematically failed by health and social care services.

Read more
Karen Addington
Breakthrough T1D
14 June 2025

Karen Addington awarded MBE in King's Birthday Honours

Our CEO received the MBE in recognition of her exceptional services to people with type 1 diabetes (T1D).

Read more
MEPs and Breakthrough T1D staff posing for a photograph at the European Parliament
Breakthrough T1D
6 June 2025

Breakthrough T1D helps organise event at the European Parliament

Breakthrough T1D has helped organise an event hosted by Tomislav Sokol titled ‘Accelerating Breakthroughs to Address Unmet Needs in Type 1 Diabetes.’